Clinical effectiveness of microsurgery for pediatric craniopharyngiomas
ZHOU Liang-xue,CAI Bo-wen,JIANG S,JU Yan,XU Jian-guo,YOU Chao
DOI: https://doi.org/10.3969/j.issn.1009-153X.2013.11.004
2013-01-01
Abstract:ObjectiveTo investigate the clinical effectiveness of microsurgery for pediatric craniopharyngiomas.MethodsOne hundred and twelve consecutive pediatric patients with craniopharyngioma received microsurgery, of whom, 29 via subfrontal approach,43 via subfrontal pterional approach, 8 via frontal interhemispheric approach, 21 via transcallosal-septum pellucidum-interforniceal approach, 4 via transsphenoidal approach and 7 via other approaches, from January 2006 to December 2011 in our hospital. The patients with residual tumor received radiotherapy after operation.ResultsAccording to the Hoffman's grade of the tumor resection, grade 1, 2, 3,4 and 5 was achieved in 86, 17, 5, 2 and 2 patients, respectively. The pituitary stalk was reserved in 95 patients, partially resected in 11and completely resected in 6. The symptoms were improved in 97 patients and worsened in 15 after operation. Diabetes insipidus,electrolyte disturbances, transient decline in visual acuity, transient mutism, symptoms of hypothalamic injury and epilepsy occurred in78, 73, 10, 10, 9 and 7 patients after operation, respectively. One hundred and two patients, of whom, 80, 15, 7, 7 and 7 patients were belonged to grade 1, 2, 3, 4 and 5, respectively, were followed up for 58 months(range, 20~90 months). Seven patients recurred in grade1, 6 recurred in grade 2, and all patients recurred in grade 3~5. The patients with growth hormone replacement was taller than those without by an average of 4.3 cm. Ninety-six patients(94.1%, 96/102) survived more than 4.5 years and 3(2.9%, 3/102) died within 1year.ConclusionsThe microsurgery should be performed through individualized surgical approach in pediatric patients with craniopharyngioma and the neuroendoscopic assistance can increase the rate of total resection and decrease the rate of postoperative complication. Postoperative radiotherapy for patient with residual tumor can reduce recurrence. Hormone replacement therapy can improve the patients' quality of life.